A key part of Biden's plan to combat Covid is at risk as FDA meets to debate booster shots
September 17, 2021 at 06:00 AM EDT
A key FDA panel meets Friday to debate and vote at around 2:30 p.m. ET on Pfizer and BioNTech's application to offer booster shots to the general public.
